Cargando…

Deconstructing the Treatment Effect of Remdesivir in the Adaptive Coronavirus Disease 2019 (COVID-19) Treatment Trial-1: Implications for Critical Care Resource Utilization

BACKGROUND: The Adaptive Coronavirus Disease 2019 (COVID-19) Treatment Trial-1 (ACTT-1) found that remdesivir therapy hastened recovery in patients hospitalized with COVID-19, but the pathway for this improvement was not explored. We investigated how the dynamics of clinical progression changed alon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fintzi, Jonathan, Bonnett, Tyler, Sweeney, Daniel A, Huprikar, Nikhil A, Ganesan, Anuradha, Frank, Maria G, McLellan, Susan L F, Dodd, Lori E, Tebas, Pablo, Mehta, Aneesh K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Major Articles and Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8499739/ https://www.ncbi.nlm.nih.gov/pubmed/34409989 http://dx.doi.org/10.1093/cid/ciab712

Ejemplares similares

Unraveling the Treatment Effect of Baricitinib on Clinical Progression and Resource Utilization in Hospitalized COVID-19 Patients: Secondary Analysis of the Adaptive COVID-19 Treatment Randomized Trial-2
por: Fintzi, Jonathan, et al.
Publicado: (2022)

Cost-effectiveness of Remdesivir and Dexamethasone for COVID-19 Treatment in South Africa
por: Jo, Youngji, et al.
Publicado: (2021)

Remdesivir for the Treatment of Covid-19 — Final Report
por: Beigel, John H., et al.
Publicado: (2020)

Remdesivir and Mortality in Patients With Coronavirus Disease 2019
por: Diaz, George A, et al.
Publicado: (2021)

Experience of Treating COVID-19 With Remdesivir and Convalescent Plasma in a Resource-Limited Setting: A Prospective, Observational Study
por: Koirala, Janak, et al.
Publicado: (2021)

Early Outpatient Treatment With Remdesivir in Patients at High Risk for Severe COVID-19: A Prospective Cohort Study
por: Rajme-López, Sandra, et al.
Publicado: (2022)

Viral Resistance Analyses From the Remdesivir Phase 3 Adaptive COVID-19 Treatment Trial-1 (ACTT-1)
por: Hedskog, Charlotte, et al.
Publicado: (2023)

Remdesivir Treatment in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19): A Comparative Analysis of In-hospital All-cause Mortality in a Large Multicenter Observational Cohort
por: Mozaffari, Essy, et al.
Publicado: (2021)

Remdesivir Versus Standard-of-Care for Severe Coronavirus Disease 2019 Infection: An Analysis of 28-Day Mortality
por: Olender, Susan A, et al.
Publicado: (2021)

Clinical Antiviral Efficacy of Remdesivir in Coronavirus Disease 2019: An Open-Label, Randomized Controlled Adaptive Platform Trial (PLATCOV)
por: Jittamala, Podjanee, et al.
Publicado: (2023)

Remdesivir Use in Patients Requiring Mechanical Ventilation due to COVID-19
por: Lapadula, Giuseppe, et al.
Publicado: (2020)

Deconstructing the Dogma: Systematic Literature Review and Meta-analysis of Adjunctive Gentamicin and Rifampin in Staphylococcal Prosthetic Valve Endocarditis
por: Ryder, Jonathan H, et al.
Publicado: (2022)

Remdesivir Use Compared With Supportive Care in Hospitalized Patients With Severe COVID-19: A Single-Center Experience
por: Kalligeros, Markos, et al.
Publicado: (2020)

Anatomical Site, Viral Ribonucleic Acid Abundance, and Time of Sampling Correlate With Molecular Detection of Severe Acute Respiratory Syndrome Coronavirus 2 During Infection
por: Lantry, F Julian, et al.
Publicado: (2021)

Remdesivir Is Associated With Reduced Mortality in COVID-19 Patients Requiring Supplemental Oxygen Including Invasive Mechanical Ventilation Across SARS-CoV-2 Variants
por: Mozaffari, Essy, et al.
Publicado: (2023)

COVID-19 Patient-Reported Symptoms Using FLU-PRO Plus in a Cohort Study: Associations With Infecting Genotype, Vaccine History, and Return to Health
por: Richard, Stephanie A, et al.
Publicado: (2022)

COVID-19 Outcomes Among US Military Health System Beneficiaries Include Complications Across Multiple Organ Systems and Substantial Functional Impairment
por: Richard, Stephanie A, et al.
Publicado: (2021)

Characterization of Heavily Treatment-Experienced People With HIV and Impact on Health Care Resource Utilization in US Commercial and Medicare Advantage Health Plans
por: Priest, Julie, et al.
Publicado: (2021)

Valorization of sugarcane bagasse by chemical pretreatment and enzyme mediated deconstruction
por: Thite, Vihang S., et al.
Publicado: (2019)

Travel-Related Risk Behaviors and Antibiotic Use Among Older Travelers
por: Costello, Varea H, et al.
Publicado: (2021)

Favipiravir for Treatment of Outpatients With Asymptomatic or Uncomplicated Coronavirus Disease 2019: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial
por: Holubar, Marisa, et al.
Publicado: (2022)

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
por: Kalil, Andre C., et al.
Publicado: (2020)

The place for remdesivir in COVID-19 treatment
por: Young, Barnaby, et al.
Publicado: (2021)

Deconstructing cosmology
por: Sanders, Robert H
Publicado: (2016)

Deconstruction and Holography
por: Jejjala, Vishnu, et al.
Publicado: (2003)

Deconstructing the OSCE
por: Cooper, Deborah
Publicado: (2017)

Deconstructing Ageism
por: Reynolds, Laurinda
Publicado: (2020)

Deconstructing Dizziness
por: Kaski, Diego, et al.
Publicado: (2021)

Diabetes Mellitus and Tuberculosis Treatment Outcomes in Pune, India
por: Mave, Vidya, et al.
Publicado: (2021)

Vitamin D Supplementation Does Not Affect Metabolic Changes Seen With ART Initiation
por: Muhammad, Josh, et al.
Publicado: (2017)

Sustained Impact of the Coronavirus Disease 2019 Pandemic on Hepatitis C Virus Treatment Initiations in the United States
por: Hoenigl, Martin, et al.
Publicado: (2022)

Optimal Duration of Systemic Corticosteroids in Coronavirus Disease 2019 Treatment: A Systematic Review and Meta-analysis
por: Ssentongo, Paddy, et al.
Publicado: (2023)

Symptom Duration and Resolution With Early Outpatient Treatment of Convalescent Plasma for Coronavirus Disease 2019: A Randomized Trial
por: Baksh, Sheriza N, et al.
Publicado: (2023)

Clinical, Immunological, and Virological SARS-CoV-2 Phenotypes in Obese and Nonobese Military Health System Beneficiaries
por: Epsi, Nusrat J, et al.
Publicado: (2021)

Remdesivir in Coronavirus Disease 2019 (COVID-19) treatment: a review of evidence
por: Lin, Hui Xian Jaime, et al.
Publicado: (2021)

Remdesivir treatment and transient bradycardia in patients with coronavirus diseases 2019 (COVID-19)
por: Pallotto, Carlo, et al.
Publicado: (2021)

Real-Life Effectiveness and Safety of Baricitinib as Adjunctive to Standard-of-Care Treatment in Hospitalized Patients With Severe Coronavirus Disease 2019
por: Tziolos, Nikolaos, et al.
Publicado: (2021)

A High Frequency of Candida auris Blood Stream Infections in Coronavirus Disease 2019 Patients Admitted to Intensive Care Units, Northwestern India: A Case Control Study
por: Rajni, Ekadashi, et al.
Publicado: (2021)

Pulmonary administration of remdesivir in the treatment of COVID-19
por: Rasmussen, Henrik Berg, et al.
Publicado: (2020)

Remdesivir for the treatment of COVID-19: author's response
por: Lee, Todd C., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vdshpb1nm2por3b2kdresrlv9i